Search: WFRF:(Palmqvist Lars 1965) > Decreased survival ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05816naa a2200661 4500 | |
001 | oai:DiVA.org:liu-98699 | |
003 | SwePub | |
008 | 131011s2013 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:kth-139281 | |
009 | oai:gup.ub.gu.se/189404 | |
009 | oai:prod.swepub.kib.ki.se:127866694 | |
009 | oai:DiVA.org:uu-214024 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-986992 URI |
024 | 7 | a https://doi.org/10.1002/ajh.235492 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-1392812 URI |
024 | 7 | a https://gup.ub.gu.se/publication/1894042 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1278666942 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2140242 URI |
040 | a (SwePub)liud (SwePub)kthd (SwePub)gud (SwePub)kid (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Jakobsen Falk, Ingridu Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet4 aut0 (Swepub:liu)ingja10 |
245 | 1 0 | a Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase |
264 | c 2013-09-09 | |
264 | 1 | b John Wiley & Sons,c 2013 |
338 | a electronic2 rdacarrier | |
500 | a QC 20140108 | |
520 | a De novo acute myeloid leukemia with normal karyotype (NK-AML) comprises a large group of patients with no common cytogenetic alterations and with a large variation in treatment response. Single-nucleotide polymorphisms (SNPs) in genes related to the metabolism of the nucleoside analogue AraC, the backbone in AML treatment, might affect drug sensitivity and treatment outcome. Therefore, SNPs may serve as prognostic biomarkers aiding clinicians in individualized treatment decisions, with the aim of improving patient outcomes. We analyzed polymorphisms in genes encoding cytidine deaminase (CDA 79A>C rs2072671 and −451C>T rs532545), 5′-nucleotidase (cN-II 7A>G rs10883841), and deoxycytidine kinase (DCK 3′UTR 948T>C rs4643786) in 205 de novo NK-AML patients. In FLT3-internal tandem duplication (ITD)-positive patients, the CDA 79C/C and −451T/T genotypes were associated with shorter overall survival compared to other genotypes (5 vs. 24 months, P < 0.001 and 5 vs. 23 months, P = 0.015, respectively), and this was most pronounced in FLT3-ITD-positive/NPM1-positive patients. We observed altered in vitro sensitivity to topoisomerase inhibitory drugs, but not to nucleoside analogues, and a decrease in global DNA methylation in cells carrying both CDA variant alleles. A shorter survival was also observed for the cN-II variant allele, but only in FLT3-ITD-negative patients (25 vs. 31 months, P = 0.075). Our results indicate that polymorphisms in genes related to nucleoside analog drug metabolism may serve as prognostic markers in de novo NK-AML | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a MEDICINE | |
653 | a MEDICIN | |
653 | a Nothing to report | |
700 | 1 | a Fyrberg, Annau Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet4 aut0 (Swepub:liu)annfy07 |
700 | 1 | a Paul, Esbjörnu Karolinska Institutet, Stockholm, Sweden4 aut |
700 | 1 | a Nahi, Harethu Karolinska Institutet,Karolinska Institutet, Stockholm, Sweden4 aut |
700 | 1 | a Hermanson, Monicau Uppsala universitet,Medicinsk genetik4 aut0 (Swepub:uu)moniherm |
700 | 1 | a Rosenquist, Richard Brandellu Uppsala universitet,Hematologi och immunologi4 aut0 (Swepub:uu)richrose |
700 | 1 | a Höglund, Martinu Uppsala universitet,Hematologi4 aut0 (Swepub:uu)martinhl |
700 | 1 | a Palmqvist, Lars,d 1965u Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin,Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine,University of Gothenburg, Sweden4 aut0 (Swepub:gu)xpalla |
700 | 1 | a Stockelberg, Dick,d 1950u Sahlgrenska University Hospital, Gothenburg, Sweden4 aut0 (Swepub:gu)xstodi |
700 | 1 | a Wei, Yuan,d 1978u Sahlgrenska University Hospital, Gothenburg, Sweden4 aut0 (Swepub:gu)xweiyu |
700 | 1 | a Gréen, Henriku KTH,Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Genteknologi,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:kth)u11x12gx |
700 | 1 | a Lotfi, Kouroshu Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,Klinisk farmakologi4 aut0 (Swepub:liu)koulo97 |
710 | 2 | a Linköpings universitetb Avdelningen för läkemedelsforskning4 org |
773 | 0 | t American Journal of Hematologyd : John Wiley & Sonsg 88:12, s. 1001-1006q 88:12<1001-1006x 0361-8609x 1096-8652 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:655527/FULLTEXT01.pdfx primaryx Raw objecty fulltext:postprint |
856 | 4 | u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.23549 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-98699 |
856 | 4 8 | u https://doi.org/10.1002/ajh.23549 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-139281 |
856 | 4 8 | u https://gup.ub.gu.se/publication/189404 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:127866694 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-214024 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.